{"filing":{"accession_number":"0001140361-26-034689","cik":"0001281895","ticker":"RCKTW","company_name":"ROCKET PHARMACEUTICALS, INC.","form":"8-K","filing_date":"2026-08-27","report_date":"2026-08-21","primary_document":"ef20081170_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126034689/ef20081170_8k.htm"},"events":[{"id":30016,"run_id":27511,"accession_number":"0001140361-26-034689","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses adoption of a company-wide Severance and Change in Control Program and execution of three executive employment agreements (Shah, Wilson, and Stevens Amendment) that establish compensatory arrangements including base salaries, target bonuses, and severance benefits for named executives. This is a classic Item 5.02(e) disclosure of compensatory arrangements for officers, distinct from a departure or appointment event.","company_name":"ROCKET PHARMACEUTICALS, INC.","ticker":"RCKTW","filing_date":"2026-08-27","form":"8-K","submitted_at":null,"items":[{"id":32495,"accession_number":"0001140361-26-034689","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses adoption of a company-wide Severance and Change in Control Program and execution of three executive employment agreements (Shah, Wilson, and Stevens Amendment) that establish compensatory arrangements including base salaries, target bonuses, and severance benefits for named executives. This is a classic Item 5.02(e) disclosure of compensatory arrangements for officers, distinct from a departure or appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T20:09:24.575101+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32495,"accession_number":"0001140361-26-034689","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses adoption of a company-wide Severance and Change in Control Program and execution of three executive employment agreements (Shah, Wilson, and Stevens Amendment) that establish compensatory arrangements including base salaries, target bonuses, and severance benefits for named executives. This is a classic Item 5.02(e) disclosure of compensatory arrangements for officers, distinct from a departure or appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T20:09:24.575101+00:00","company_name":"ROCKET PHARMACEUTICALS, INC.","ticker":"RCKTW","filing_date":"2026-08-27"}]}